tiprankstipranks
Santhera Pharmaceuticals Holding (SPHDF)
OTHER OTC:SPHDF

Compare Santhera Pharmaceuticals Holding (SPHDF) vs. Competitors

40 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Santhera Pharmaceuticals Holding
$22.28
$301.90M
-4.43
60.85%
1 Buy
0 Hold
0 Sell
Moderate Buy
Molecular Partners AG
CHF3.41
CHF126.78M
-2.03
-5.71%
1 Buy
0 Hold
0 Sell
Moderate Buy
Basilea Pharmaceutica
CHF52.60
CHF640.06M
19.69
16.42%
1 Buy
0 Hold
0 Sell
Moderate Buy
Idorsia Ltd
CHF3.71
CHF1.13B
-5.11
188.13%
2 Buy
0 Hold
0 Sell
Moderate Buy
Newron Pharmaceuticals SpA
CHF16.44
CHF283.37M
-22.51
82.09%
1 Buy
0 Hold
0 Sell
Moderate Buy
Xlife Sciences Ltd.
CHF22.90
CHF132.65M
4.27
16.75%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
SPHDF
Santhera Pharmaceuticals Holding
23.73
7.68
47.82%
CH:MOLN
Molecular Partners AG
3.14
0.01
0.32%
CH:BSLN
Basilea Pharmaceutica
52.10
6.50
14.25%
CH:IDIA
Idorsia Ltd
4.47
2.82
171.00%
CH:NWRN
Newron Pharmaceuticals SpA
13.62
6.34
87.09%
CH:XLS
Xlife Sciences Ltd.
23.00
3.10
15.58%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts